UNSPSC 51384605: Benzydamine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H23N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4O21U048EF, chemically known as 1-propanamine, n,n-dimethyl-3-((1-(phenylmethyl)-1h-indazol-3-yl)oxy)- but generally known as benzydamine, which bears US NIH Compound Identifier 12555. Benzydamine most often comes in base, hydrochloride, n-oxide, and salicylate forms.

UNSPSC 51384605 Benzydamine is a Commodity code that designates a specific pharmaceutical agent, but the recent state and local procurement activity tagged under it does not align with benzydamine sourcing. Seminole County, Florida issued IFB 60459723LAS in June 2026 for naloxone and drug deactivation systems, a mismatch suggesting either miscoding or cross-category procurement consolidation by the issuing body. State and local governments under this code nominally source benzydamine, an anti-inflammatory topical or oral pharmaceutical, but the available record does not show typical demand signals for this agent within state or local health systems, emergency medical services, or community health programs.

The single recent opportunity on record — Seminole County's naloxone and safe drug deactivation systems bid with a response deadline of July 26, 2023 — does not represent benzydamine procurement and provides limited visibility into authentic market activity for this Commodity code. Geographic and issuing-body concentration cannot be reliably characterized from one unrelated solicitation. No other recent state or local opportunities appear under this code in the available data, indicating either very low activity or systematic miscoding at the source. Business development professionals should verify whether their benzydamine inventory or pharmaceutical supply capability aligns with actual state and local demand before pursuing opportunities nominally tagged under this code.